Kainic acid alters neurochemical development in fetal rat brain aggregating cell cultures.
D000110:Acetylcholinesterase / Q000378:metabolism; D000375:Aging; D000818:Animals; D001921:Brain / Q000166:cytology / Q000187:drug effects* / Q000201:enzymology; D002449:Cell Aggregation / Q000187:drug effects; D002795:Choline O-Acetyltransferase / Q000378:metabolism; D006152:Cyclic GMP / Q000378:metabolism; D004296:Dopa Decarboxylase / Q000378:metabolism; D004305:Dose-Response Relationship, Drug; D005968:Glutamate Decarboxylase / Q000378:metabolism; D007608:Kainic Acid / Q000494:pharmacology*; D008995:Monoamine Oxidase / Q000378:metabolism; D009474:Neurons / Q000187:drug effects; D009924:Organ Culture Techniques; D011759:Pyrrolidines / Q000494:pharmacology*; D051381:Rats; D014364:Tryptophan; D014446:Tyrosine 3-Monooxygenase / Q000378:metabolism
D011759:Pyrrolidines; D014364:Tryptophan; D014446:Tyrosine 3-Monooxygenase; D008995:Monoamine Oxidase; D002795:Choline O-Acetyltransferase; D000110:Acetylcholinesterase; D004296:Dopa Decarboxylase; D005968:Glutamate Decarboxylase; D006152:Cyclic GMP; D007608:Kainic Acid